Activation of the NLRP3 inflammasome has been shown to contribute to the development of a number of cardiovascular diseases (CVDs), representing a key pathogenetic mechanism in the formation and progression of atherosclerosis, and in the myocardial response to ischemic and nonischemic injury (2, 3). Here, NLRP3 is linked to cardiovascular disorder.